Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xencor Inc Director's Dealing 2018

Aug 17, 2018

32653_dirs_2018-08-17_10ffeaa2-d880-4500-af97-8b41a9183081.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2018-08-17

Reporting Person: Foster Paul A (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-08-17 Common Stock M 3659 $11.05 Acquired 8611 Direct
2018-08-17 Common Stock S 3659 $40.10 Disposed 4952 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-08-17 Stock Option (right to buy) $11.05 M 3659 Disposed 2024-02-20 Common Stock (3659) Direct

Footnotes

F1: The stock option is fully vested.